Uniting past and present athletes from the internationally-renowned All Blacks, All Black Sevens, Black Ferns and Black Ferns Sevens, the campaign follows global research from Bupa revealing that 71% of young adults (18–44 year-olds) believe role models can inspire positive health change.Each player is captured not just as an athlete but as a person with a word they have personally chosen to represent their unique health and wellness story – from depression, anxiety and loss, to stroke, cancer and diabetes – displayed on the individual, revealing the human behind the jersey.Ruby Tui, current Black Fern #235, 2020 Olympic gold medallist, and 2021 World Cup winner, said: "There are a lot of eyes on you when you're a high-performance athlete, but the human story beyond the pitch can often be overlooked when it's just as important for us as individuals. I hope this campaign from Bupa sheds light on the importance of our individual health and wellness journeys and inspires more people to make their health a priority that they talk about openly and honestly."Among the stories featured, 2011 World Cup winner Aaron Cruden reflects on his battle with testicular cancer, while Maiakawanakaulani Roos, the youngest-ever captain of the Black Ferns, opens up about how personal loss during high school shaped her approach to teamwork and leadership. All stories can be found in more depth, alongside their bio below.To complement these personal narratives, Iain Saunders, Mental Skills Coach for the Black Ferns, shares five key lessons that can positively impact the mental and physical health of athletes and non-athletes alike:Work through it together: High performance isn't a solo act – and personal challenges needn't be either. The best teams thrive on connection, shared experience, and collective energy. Lean into your people and let them lean on you. Wellbeing is non-negotiable: High performance teams don't win championships by burning out

Dr Jose-Carlos Gutiérrez- Ramos is the Chief Science Officer at Danaher Corporation. He has held senior drug discovery roles at Pfizer, Abbvie, and GSK. As CEO and President of Synlogic, he led the company from early drug discovery to clinical stage and public marketsHe brings a wealth of experience across biotechs and pharmaceutical companies, combined with deep expertise in science and tech for successful drug discovery, drug development programmes, and marketed drugsThe appointment strengthens the company's commercial capabilities, life sciences innovation, and R&D offering, to advance Genomics' mission of changing the future of healthcareOXFORD, England, Jan. 9, 2025 /PRNewswire/ -- Genomics , a healthcare company using large-scale genetic information to develop innovative precision healthcare tools and to bring new understanding to drug discovery, today announced the appointment of Dr Jose-Carlos Gutiérrez-Ramos to its Board. The appointment will support the company's rapid growth and strengthen its commercial offering globally, with a focus on scaling its life sciences business. The announcement coincides with significant Genomics presence at the J.P